Naltrexone Not Yet Recruiting Phase 3 Trials for Endometriosis Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03970330Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis